The pro-tumorigenic effect of TGFβ in Smad4-deficient cancers remains incompletely understood, but the loss of Smad4 may allow cancer cells to escape TGFβ-mediated growth arrest and immune surveillance9,14–18. This evidence concerns the gene TGFB1 and cancer.